Viral anti - cancer therapy

Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 7

Abstract

Poor effectiveness of the conventional methods in treating cancer diseases has become one of the causes of searching for alternative ways of therapy. Extensive genetic, biological and biotechnological research has made it possible to understand better the mechanisms which control the cell cycle and identification of the factors involved in cancerogenesis. What is more, understanding the viral nature and viral infection mechanisms has created a scientific basis to develop new methods of the anticancer therapy by means of using viruses. Thanks to natural tropism of viruses to specific tissues and organ cells and the possibility of inserting a desirable genetic modification to the viral genome we can use viruses as anticancer factors. Virotherapy is safe if highly specified viruses in respect to structurally and functionally alternated cancer cells are applied and if they are strengthened by means of genetic modifications. It is crucial to modify the virus in such a way so that it could evoke lytic of a cell after having reached it. Viral vectors may be carriers for factors (for example proteins and prodrugs) involved in cell death, and they may induce a specific anticancer resistance and increase cancer cells sensitivity to chemotherapeutics. Vectors are created mainly on the basis of adenoviruses, herpes viruses, rabdoviruses and reoviruses.

Authors and Affiliations

Paulina Błażejewska, Anna Goździcka - Józefiak

Keywords

Related Articles

Genetic basis of melanoma: own investgations and literature review

Melanoma like other cancers is a genetic disease including involvement of environmental factors and genetic predisposition. The genetic base of melanoma is the subject of intensive investigations carried out by differe...

Treatment of advanced invasive Thymomas in experience of Oncology Department at Regional Centre of Lung Diseases in Poznań and Department of Thoracic Surgery, Poznań University of Medical Sciences

Introduction: Thymoma is a rare neoplasm, deriving from epithelial tissue of Thymus. ADOC, PAC, PE and VIP are most frequently used combintions. Materials and method: Retrospective analysis including 13 patients treated...

The off-label drug use in oncology and hematology with emphasis on age groups

Drug approval refers to indications, patient characteristics, dosage, route of administration, contraindications and warnings. The term „off-label prescribing” refers to the use of a drug outside the terms of its marketi...

Epigenetic regulation of transcription factor STAT3 activity in cancer cells

The transcription factor STAT3 is increasingly viewed as an oncogene. Activated STAT3 is pro-proliferative, anti-apoptotic and oncogenic. There is growing evidence for the epigenetic regulation of STAT3 activity in can...

Hormonoterapia zastępcza a ryzyko zachorowania na raka jajnika

Hormonalna terapia zastępcza, stosowana głównie w leczeniu menopauzalnych objawów wypadowych, zwiększa u kobiet ryzyko powstawania raka piersi i trzonu macicy, natomiast jej wpływ na rozwój raka jajnika nie jest dokład...

Download PDF file
  • EP ID EP96445
  • DOI -
  • Views 80
  • Downloads 0

How To Cite

Paulina Błażejewska, Anna Goździcka - Józefiak (2005). Viral anti - cancer therapy. Współczesna Onkologia, 9(7), 279-283. https://europub.co.uk/articles/-A-96445